Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory effects. In a phase 2 trial involving patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback